Φορτώνει......
Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease
No treatment until now has directly targeted the mechanisms responsible for the development and growth of cysts in autosomal dominant polycystic kidney disease (ADPKD). Strong rationale and preclinical studies using in vitro and in vivo models justified the launching of two large phase 3 clinical tr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Nephrol Dial Transplant |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657439/ https://ncbi.nlm.nih.gov/pubmed/30312438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy297 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|